Canadian Initiative for Outcomes in Rheumatology cAre (CIORA)

CIORA is a unique granting division of the Canadian Rheumatology Association Foundation (CRAF) committed to being a catalyst for improving the care of Canadians living with all rheumatic diseases.

CIORA’s grant program supports sustainable projects related to:

  • Academic clinical research initiatives related to all rheumatic diseases
  • Clinical research initiatives for community rheumatologists related to all rheumatic diseases

CIORA will have achieved its mandate when:

  • Just like cancer and diabetes, all rheumatic diseases are widely recognized by doctors, patients, government and the general population as a serious chronic illness, urgently in need of early intervention and resource allocation;
  • Efficient and appropriate systems for rheumatic disease care and referrals are in place across the country;
  • Optimal care is available to all Canadians who need it, regardless of where they live.

CIORA is issuing another call for grants!

CIORA Online Grant Application System opens on January 29, 2024.
Letter of Intent must be submitted by March 8, 2024.
CIORA Online Grant Application submission deadline is April 5, 2024, at 17:00 (Pacific Time).
Grant notifications will be sent out in July 2024.

Guidelines and Templates

Need Help?

 CIORA Webinar

CIORA Research Projects of the Past, Present, and Future 

Presented on Wednesday, September 27, 2023 by Dr. Janet Pope

This webinar features CIORA projects from the Past, Present, and  Future.  Investigators discuss their findings, next steps, and how their research impacted rheumatology care and their careers.

CIORA Sponsors

CIORA (Canadian Initiative for Outcomes in Rheumatology cAre) has been funded by Abbott (now AbbVie) as the founding sponsor since 2006 and as of 2009 it has become multi-sponsored.  The Canadian Rheumatology Association would like to thank all of our CIORA sponsors for their support in 2024.

$125,000 to $150,000

Pfizer logo

$50,000 to $75,000

abbvie logo

$30,000 to $50,000

Eli Lilly logo